Ala Ghobadian, Saba Mokhtari, Behnam Shariati, Leila Kamalzadeh, Mohsen Shati, Mehrdad Eftekhar Ardebili, . . . Mohammadreza Shalbafan. (2022). Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. BMC.
Chicago Style (17th ed.) CitationAla Ghobadian, Saba Mokhtari, Behnam Shariati, Leila Kamalzadeh, Mohsen Shati, Mehrdad Eftekhar Ardebili, Masoomeh Yarahmadi, and Mohammadreza Shalbafan. Granisetron-mediated Augmentation of Sertraline Therapeutic Effect in Obsessive-compulsive Disorder: A Double-blind Placebo-controlled, Randomized Clinical Trial. BMC, 2022.
MLA (9th ed.) CitationAla Ghobadian, et al. Granisetron-mediated Augmentation of Sertraline Therapeutic Effect in Obsessive-compulsive Disorder: A Double-blind Placebo-controlled, Randomized Clinical Trial. BMC, 2022.